Everett K Henry1,2, Juan M Inclan-Rico1,2, Mark C Siracusa1,2. 1. Center for Immunity and Inflammation, New Jersey Medical School, Rutgers-The State University of New Jersey, Newark, New Jersey, USA. 2. Department of Medicine, New Jersey Medical School, Rutgers-The State University of New Jersey, Newark, New Jersey, USA.
Abstract
PURPOSE OF REVIEW: It is well established that T helper type 2 (TH2) immune responses are necessary to provide protection against helminth parasites but also to promote the detrimental inflammation associated with allergies and asthma. Given the importance of type 2 immunity and inflammation, many studies have focused on better understanding the factors that regulate TH2 cell development and activation. As a result, significant progress has been made in understanding the signaling pathways and molecular events necessary to promote TH2 cell polarization. In addition to the adaptive compartment, emerging studies are better defining the innate immune pathways needed to promote TH2 cell responses. Given the recent and substantial growth of this field, the purpose of this review is to highlight recent studies defining the innate immune events that promote immunity to helminth parasites and allergic inflammation. RECENT FINDINGS: Emerging studies have begun to elucidate the importance of cytokine alarmins such as thymic stromal lymphopoietin (TSLP), IL-25 (IL-17E) and IL-33 in promoting type 2 immunity and inflammation following helminth challenge or exposure to allergens. Specifically, recent reports have begun to define the complex cellular networks these alarmins activate and their contribution to type 2 immunity and inflammation. SUMMARY: Our increased understanding of the pathways that regulate type 2 cytokine-mediated immunity and inflammation have revealed novel therapeutic targets to treat both helminth infections and allergic disease states.
PURPOSE OF REVIEW: It is well established that T helper type 2 (TH2) immune responses are necessary to provide protection against helminth parasites but also to promote the detrimental inflammation associated with allergies and asthma. Given the importance of type 2 immunity and inflammation, many studies have focused on better understanding the factors that regulate TH2 cell development and activation. As a result, significant progress has been made in understanding the signaling pathways and molecular events necessary to promote TH2 cell polarization. In addition to the adaptive compartment, emerging studies are better defining the innate immune pathways needed to promote TH2 cell responses. Given the recent and substantial growth of this field, the purpose of this review is to highlight recent studies defining the innate immune events that promote immunity to helminth parasites and allergic inflammation. RECENT FINDINGS: Emerging studies have begun to elucidate the importance of cytokine alarmins such as thymic stromal lymphopoietin (TSLP), IL-25 (IL-17E) and IL-33 in promoting type 2 immunity and inflammation following helminth challenge or exposure to allergens. Specifically, recent reports have begun to define the complex cellular networks these alarmins activate and their contribution to type 2 immunity and inflammation. SUMMARY: Our increased understanding of the pathways that regulate type 2 cytokine-mediated immunity and inflammation have revealed novel therapeutic targets to treat both helminth infections and allergic disease states.
Entities:
Keywords:
TH2 cells; Type 2 cytokines; allergies and asthma; heminth parasites; innate immunity; mucosal immunology
Authors: Qian Liu; Zhugong Liu; Cristina T Rozo; Hossein A Hamed; Farhang Alem; Joseph F Urban; William C Gause Journal: J Immunol Date: 2007-09-15 Impact factor: 5.422
Authors: Michael R Howitt; Sydney Lavoie; Monia Michaud; Arthur M Blum; Sara V Tran; Joel V Weinstock; Carey Ann Gallini; Kevin Redding; Robert F Margolskee; Lisa C Osborne; David Artis; Wendy S Garrett Journal: Science Date: 2016-02-04 Impact factor: 47.728
Authors: L H Faccioli; V F Mokwa; C L Silva; G M Rocha; J I Araujo; M A Nahori; B B Vargaftig Journal: Mediators Inflamm Date: 1996 Impact factor: 4.711
Authors: Timotheus Y F Halim; You Yi Hwang; Seth T Scanlon; Habib Zaghouani; Natalio Garbi; Padraic G Fallon; Andrew N J McKenzie Journal: Nat Immunol Date: 2015-11-02 Impact factor: 25.606
Authors: Christoph S N Klose; Tanel Mahlakõiv; Jesper B Moeller; Lucille C Rankin; Anne-Laure Flamar; Hiroki Kabata; Laurel A Monticelli; Saya Moriyama; Gregory Garbès Putzel; Nikolai Rakhilin; Xiling Shen; Evi Kostenis; Gabriele M König; Takashi Senda; Dustin Carpenter; Donna L Farber; David Artis Journal: Nature Date: 2017-09-06 Impact factor: 49.962
Authors: Karen Elizabeth Nava-Castro; Lenin Pavón; Luis Enrique Becerril-Villanueva; María Dolores Ponce-Regalado; Hugo Aguilar-Díaz; Mariana Segovia-Mendoza; Jorge Morales-Montor Journal: Pathogens Date: 2022-03-01